TW323954B - Pharmaceutical composition used in the treatment of hypertriglyceridemia, atheroscleorsis and hypercholecterolemia - Google Patents

Pharmaceutical composition used in the treatment of hypertriglyceridemia, atheroscleorsis and hypercholecterolemia

Info

Publication number
TW323954B
TW323954B TW084102716A TW84102716A TW323954B TW 323954 B TW323954 B TW 323954B TW 084102716 A TW084102716 A TW 084102716A TW 84102716 A TW84102716 A TW 84102716A TW 323954 B TW323954 B TW 323954B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
composition used
hypercholecterolemia
atheroscleorsis
hypertriglyceridemia
Prior art date
Application number
TW084102716A
Other languages
Chinese (zh)
Inventor
Gary A Flynn
John F French
Richard C Dage
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of TW323954B publication Critical patent/TW323954B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

A pharmaceutical composition used to reduce total serum cholesterol, which comprises a therapeutically effective amount of the compound [4S-[4α,7α(R*),12bB]]-7-[(1-oxy-2(S)- thioacetyl - 3 - phenpropyl ) amino]-1,2,3,4,6,7,8,12b- octahydrogen -6- oxy - pyridyl[2,1-a][2] azatropylidene-4-carboxylic acid and at least one pharmaceutically acceptable carrier.
TW084102716A 1994-03-24 1995-03-21 Pharmaceutical composition used in the treatment of hypertriglyceridemia, atheroscleorsis and hypercholecterolemia TW323954B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/217,781 US5484783A (en) 1994-03-24 1994-03-24 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide and benzazapine derivatives

Publications (1)

Publication Number Publication Date
TW323954B true TW323954B (en) 1998-01-01

Family

ID=22812484

Family Applications (1)

Application Number Title Priority Date Filing Date
TW084102716A TW323954B (en) 1994-03-24 1995-03-21 Pharmaceutical composition used in the treatment of hypertriglyceridemia, atheroscleorsis and hypercholecterolemia

Country Status (20)

Country Link
US (1) US5484783A (en)
EP (1) EP0751775B1 (en)
JP (1) JPH09510220A (en)
KR (1) KR970701550A (en)
CN (1) CN1144483A (en)
AT (1) ATE217527T1 (en)
AU (1) AU705029B2 (en)
CA (1) CA2184693C (en)
DE (1) DE69526731T2 (en)
DK (1) DK0751775T3 (en)
ES (1) ES2173180T3 (en)
FI (1) FI118414B (en)
HU (1) HU226643B1 (en)
IL (1) IL113074A (en)
NO (1) NO313176B1 (en)
NZ (1) NZ282949A (en)
PT (1) PT751775E (en)
TW (1) TW323954B (en)
WO (1) WO1995025548A2 (en)
ZA (1) ZA952285B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US5834353A (en) * 1997-10-20 1998-11-10 Texas Instruments-Acer Incorporated Method of making deep sub-micron meter MOSFET with a high permitivity gate dielectric
US6378430B1 (en) 1999-10-15 2002-04-30 King Press Corporation Cylinder with plate gripping device
DE10229180A1 (en) * 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Use of vasopeptidase inhibitors in the treatment of metabolic disorders, nephropathy and AGE-associated disorders
EP1670768B1 (en) * 2003-10-08 2009-09-09 Eli Lilly And Company Compounds and methods for treating dyslipidemia

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334095A (en) * 1965-02-16 1967-08-01 Sandoz Ag Novel pyrrolo-oxazines and pyrrolo-oxazoles
US3334091A (en) * 1965-03-25 1967-08-01 Sandoz Ag Sedatives
GB1525845A (en) * 1976-07-30 1978-09-20 Ucb Sa 1,2,4,5-tetrahydro-3h-2-benzazepin-3-ones
IE50839B1 (en) * 1980-02-26 1986-07-23 Wyeth John & Brother Ltd Novel processes for preparing proline derivatives and analogous compounds
EP0042100A1 (en) * 1980-06-13 1981-12-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pyrazolopyridazine derivatives, intermediates and processes for their preparation, and medicaments containing them
US4320057A (en) * 1980-06-23 1982-03-16 American Home Products Corporation Aryl--pyrrolo--thiazepin--diones and aryl--piperidino--thiazepin--diones
US4415496A (en) * 1981-03-23 1983-11-15 Merck & Co., Inc. Bicyclic lactams
NZ204130A (en) * 1982-05-12 1986-03-14 Hoffmann La Roche Bicyclic heterocyclic compounds and pharmaceutical compositions
GB2128984B (en) * 1982-05-12 1985-05-22 Hoffmann La Roche Diaza-bicyclic compounds
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4692438A (en) * 1984-08-24 1987-09-08 Hoffmann-La Roche Inc. Pyridazo-diazepines, diazocines, and -triazepines having anti-hypertensive activity
US4584294A (en) * 1984-11-07 1986-04-22 Merck & Co., Inc. Fused tricyclic lactams as angiotensin converting enzyme inhibitors and as antihypertensive agents
CA1274832A (en) * 1985-04-30 1990-10-02 Richard Elmer Holmes 7-substituted bicyclic pyrazolidinones
CA1337654C (en) * 1986-06-13 1995-11-28 Gary A. Flynn Fused tricyclic lactams as antihypertensive agents
ZA874106B (en) * 1986-06-13 1987-12-08 Merrell Dow Pharmaceuticals Inc. Novel antihypertensive agent
US4973585A (en) * 1986-06-13 1990-11-27 Merrell Dow Pharmaceuticals Tricyclic lactams active as antihypertensive agents
GB8629875D0 (en) * 1986-12-15 1987-01-28 Hoffmann La Roche Pyridazodiazepine derivatives
US4824832A (en) * 1987-12-30 1989-04-25 Merrell Dow Pharmaceuticals Inc. Sulfhydryl containing tricyclic lactams and their pharmacological methods of use
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
GB8926512D0 (en) * 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
US5407960A (en) * 1989-12-22 1995-04-18 Schering Corporation Mercaptocycloacyl aminoacid endopeptidase inhibitors
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
US5208230A (en) * 1990-12-21 1993-05-04 Merrell Dow Pharmaceuticals Amino and nitro containing tricyclic compounds useful as inhibitors of ACE
NZ241023A (en) * 1990-12-21 1994-10-26 Merrell Dow Pharma Condensed benzazepine derivatives and pharmaceutical compositions
FR2679564A1 (en) * 1991-07-23 1993-01-29 Inst Nat Sante Rech Med NOVEL ACYLMERCAPTOALCANOLDIPEPTIDES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM.
EP0533084A1 (en) * 1991-09-16 1993-03-24 Schering Corporation Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating and preventing myointimal proliferation
RU2124503C1 (en) * 1992-05-18 1999-01-10 И.Р.Сквибб энд Санз, Инк. Heterocyclic nitrogen-containing derivatives of carboxylic acid, method of their synthesis, pharmaceutical composition
US5238932A (en) * 1992-05-20 1993-08-24 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase

Also Published As

Publication number Publication date
AU2091495A (en) 1995-10-09
NO313176B1 (en) 2002-08-26
DE69526731T2 (en) 2003-02-06
ES2173180T3 (en) 2002-10-16
EP0751775A1 (en) 1997-01-08
WO1995025548A3 (en) 1995-11-09
KR970701550A (en) 1997-04-12
FI963785A (en) 1996-09-23
ATE217527T1 (en) 2002-06-15
PT751775E (en) 2002-10-31
CA2184693C (en) 2001-01-02
CA2184693A1 (en) 1995-09-28
FI963785A0 (en) 1996-09-23
NO963989L (en) 1996-11-22
DK0751775T3 (en) 2002-08-26
HU9602603D0 (en) 1996-11-28
CN1144483A (en) 1997-03-05
IL113074A0 (en) 1995-06-29
HU226643B1 (en) 2009-05-28
AU705029B2 (en) 1999-05-13
ZA952285B (en) 1996-01-09
FI118414B (en) 2007-11-15
NZ282949A (en) 1997-07-27
EP0751775B1 (en) 2002-05-15
IL113074A (en) 2000-07-26
WO1995025548A2 (en) 1995-09-28
JPH09510220A (en) 1997-10-14
DE69526731D1 (en) 2002-06-20
NO963989D0 (en) 1996-09-23
HUT74886A (en) 1997-02-28
US5484783A (en) 1996-01-16

Similar Documents

Publication Publication Date Title
CA2203033A1 (en) Compounds and compositions for delivering active agents
EP2016950A8 (en) Pharmaceutical composition comprising an exendin-4 peptide
IL113625A0 (en) Amino acid derivatives processes for their preparation and pharmaceutical compositions containing them and their use
IL115685A0 (en) Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
IL112903A (en) GnRH antagonist peptides and their use in the preparation of a pharmaceutical composition
EP1820862A3 (en) Medical preparations for the treatment of alpha-galactosidase a deficiency
HK1010484A1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
IL117728A0 (en) Pharmaceutical compositions for transdermal administration
SI0825178T1 (en) Phenyl-substituted alkenoylguanidides, process for their preparation, their use as drugs or in diagnostic agents and drugs containing them
CA2255539A1 (en) Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
GB2343117B (en) Benzimidazole pharmaceutical composition and process of preparation
EP0582169A3 (en) Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
HUT74387A (en) Pseudodipeptide products having imidazole group and their use for producing pharmaceutical compositions
AU3986097A (en) Lipophilic polyamine esters for the site specific delivery of nitric oxide in pharmaceutical use
EP0874622A4 (en) Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
CZ63895A3 (en) 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use
AU2345695A (en) Pharmaceutical composition for transdermal delivery
HUP0002650A3 (en) 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b]-indole-1-acetamide derivatives, process for their preparation and pharmaceutical compositions containing them
TW323954B (en) Pharmaceutical composition used in the treatment of hypertriglyceridemia, atheroscleorsis and hypercholecterolemia
EG23781A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
ZA941199B (en) Physiologically active compound HS-1 and process for the preparation of the same
IL109438A0 (en) 3-Quinolyl-substituted dihydropyridines, processes for their preparation and their use in pharmaceutical compositions
AU2620600A (en) Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
HRP960117B1 (en) Bicyclic compounds, their preparation and use in pharmaceutical preparations
CA2235951A1 (en) Novel uses of mammalian ctla-8 and related reagents

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees